Literature DB >> 20713953

Neurocysticercosis: unraveling the nature of the single cysticercal granuloma.

H H García1, A E Gonzalez, S Rodriguez, V C W Tsang, E J Pretell, I Gonzales, R H Gilman.   

Abstract

A single enhancing lesion in the brain parenchyma, also called an inflammatory granuloma, is a frequent neurologic diagnosis. One of the commonest causes of this lesion is human neurocysticercosis, the infection by the larvae of the pork tapeworm, Taenia solium. Following the demonstration that viable cysticercosis cysts survive in good conditions for several years in the human brain, single cysticercal granulomas have been consistently interpreted as representing late degeneration of a long-established parasite. On the basis of epidemiologic, clinical, and laboratory evidence detailed in this article, we hypothesize that in most cases these inflammatory lesions correspond to parasites that die in the early steps of infection, likely as the natural result of the host immunity overcoming mild infections.

Entities:  

Mesh:

Year:  2010        PMID: 20713953      PMCID: PMC2931772          DOI: 10.1212/WNL.0b013e3181ed9eae

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  26 in total

1.  Short report: transient antibody response in Taenia solium infection in field conditions-a major contributor to high seroprevalence.

Authors:  H H Garcia; A E Gonzalez; R H Gilman; L G Palacios; I Jimenez; S Rodriguez; M Verastegui; P Wilkins; V C Tsang
Journal:  Am J Trop Med Hyg       Date:  2001-07       Impact factor: 2.345

2.  Cysticercosis causing single, small CT lesions in Indian patients with seizures.

Authors:  M J Chandy; V Rajshekhar; S Prakash; S Ghosh; T Joseph; J Abraham; S M Chandi
Journal:  Lancet       Date:  1989-02-18       Impact factor: 79.321

Review 3.  Neurocysticercosis: updated concepts about an old disease.

Authors:  Hector H Garcia; Oscar H Del Brutto
Journal:  Lancet Neurol       Date:  2005-10       Impact factor: 44.182

4.  A trial of antiparasitic treatment to reduce the rate of seizures due to cerebral cysticercosis.

Authors:  Héctor H Garcia; E Javier Pretell; Robert H Gilman; S Manuel Martinez; Lawrence H Moulton; Oscar H Del Brutto; Genaro Herrera; Carlton A W Evans; Armando E Gonzalez
Journal:  N Engl J Med       Date:  2004-01-15       Impact factor: 91.245

Review 5.  Imaging findings in neurocysticercosis.

Authors:  Héctor H García; Oscar H Del Brutto
Journal:  Acta Trop       Date:  2003-06       Impact factor: 3.112

6.  Single small enhancing CT lesions in Indian patients with epilepsy: clinical, radiological and pathological considerations.

Authors:  M J Chandy; V Rajshekhar; S Ghosh; S Prakash; T Joseph; J Abraham; S M Chandi
Journal:  J Neurol Neurosurg Psychiatry       Date:  1991-08       Impact factor: 10.154

Review 7.  Calcific neurocysticercosis and epileptogenesis.

Authors:  T E Nash; O H Del Brutto; J A Butman; T Corona; A Delgado-Escueta; R M Duron; C A W Evans; R H Gilman; A E Gonzalez; J A Loeb; M T Medina; S Pietsch-Escueta; E J Pretell; O M Takayanagui; W Theodore; V C W Tsang; H H Garcia
Journal:  Neurology       Date:  2004-06-08       Impact factor: 9.910

8.  Intracranial tuberculomas: a CT study.

Authors:  S Bhargava; P N Tandon
Journal:  Br J Radiol       Date:  1980-10       Impact factor: 3.039

9.  Seizure outcome in patients with a solitary cerebral cysticercus granuloma.

Authors:  Vedantam Rajshekhar; Lakshmanan Jeyaseelan
Journal:  Neurology       Date:  2004-06-22       Impact factor: 9.910

10.  Prevalence of antibodies to unique Taenia solium oncosphere antigens in taeniasis and human and porcine cysticercosis.

Authors:  Manuela Verastegui; Robert H Gilman; Hector H Garcia; Armando E Gonzalez; Yanina Arana; Cesar Jeri; Iskra Tuero; Cesar M Gavidia; Min Levine; Victor C W Tsang
Journal:  Am J Trop Med Hyg       Date:  2003-10       Impact factor: 2.345

View more
  28 in total

1.  Neurocysticercosis.

Authors:  Oscar H Del Brutto
Journal:  Neurohospitalist       Date:  2014-10

Review 2.  Cysticerci-related single parenchymal brain enhancing lesions in non-endemic countries.

Authors:  Oscar H Del Brutto; Theodore E Nash; Hector H Garcia
Journal:  J Neurol Sci       Date:  2012-05-31       Impact factor: 3.181

Review 3.  Diagnosis and treatment of neurocysticercosis.

Authors:  Theodore E Nash; Hector H Garcia
Journal:  Nat Rev Neurol       Date:  2011-09-13       Impact factor: 42.937

Review 4.  Clinical symptoms, diagnosis, and treatment of neurocysticercosis.

Authors:  Hector H Garcia; Theodore E Nash; Oscar H Del Brutto
Journal:  Lancet Neurol       Date:  2014-11-10       Impact factor: 44.182

Review 5.  An overview of travel-associated central nervous system infectious diseases: risk assessment, general considerations and future directions.

Authors:  Morteza Izadi; Arman Is'haqi; Mohammad Ali Is'haqi; Nematollah Jonaidi Jafari; Fatemeh Rahamaty; Abdolali Banki
Journal:  Asian Pac J Trop Biomed       Date:  2014-08

Review 6.  Clinical manifestations, diagnosis, and treatment of neurocysticercosis.

Authors:  Julio Sotelo
Journal:  Curr Neurol Neurosci Rep       Date:  2011-12       Impact factor: 5.081

7.  An Ambispective Cohort Study to Assess Seizure Recurrences in Children with Calcified Parenchymal Neurocysticercosis.

Authors:  Abhijit Modak; Renu Suthar; Indar Kumar Sharawat; Naveen Sankhyan; Jitendra Kumar Sahu; Prahbhjot Malhi; Niranjan Khandelwal
Journal:  Am J Trop Med Hyg       Date:  2019-10       Impact factor: 2.345

Review 8.  Immunology of Taenia solium taeniasis and human cysticercosis.

Authors:  H H Garcia; S Rodriguez; J S Friedland
Journal:  Parasite Immunol       Date:  2014-08       Impact factor: 2.280

Review 9.  Neurocysticercosis in sub-Saharan Africa: a review of prevalence, clinical characteristics, diagnosis, and management.

Authors:  Andrea Sylvia Winkler
Journal:  Pathog Glob Health       Date:  2012-09       Impact factor: 2.894

Review 10.  Immunological and molecular diagnosis of cysticercosis.

Authors:  Silvia Rodriguez; Patricia Wilkins; Pierre Dorny
Journal:  Pathog Glob Health       Date:  2012-09       Impact factor: 2.894

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.